Literature DB >> 2052614

In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

K Yamanaka1, N Ogasawara, H Yoshikawa, A Ishihama, K Nagata.   

Abstract

A system for the expression of a foreign gene derived from negative polarity RNA was developed using influenza virus, a negative-stranded RNA virus. From cDNA for the influenza virus RNA genome segment 8, the region coding for the nonstructural protein was deleted and replaced by the chloramphenicol acetyltransferase (CAT) gene. The resulting DNA sequence was placed under the control of the promoter of T7 RNA polymerase such that the antisense RNA to CAT mRNA was produced when transcribed by T7 RNA polymerase. Transfection of HeLa cells with this antisense CAT RNA in the presence of the helper ribonucleoprotein cores led to no significant production of the CAT. In contrast, when the RNA was covered with purified nucleoprotein prior to transfection, the CAT gene was efficiently expressed. This indicated that the viral RNA polymerase transcribed the RNA transfected as the RNA-nucleoprotein complexes. In addition, this system was used for analysis of the cis-acting region in transcription and the promoter structure of the viral RNA genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052614      PMCID: PMC51874          DOI: 10.1073/pnas.88.12.5369

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Reconstitution of influenza virus RNA-nucleoprotein complexes structurally resembling native viral ribonucleoprotein cores.

Authors:  K Yamanaka; A Ishihama; K Nagata
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

2.  Engineered defective interfering RNAs of Sindbis virus express bacterial chloramphenicol acetyltransferase in avian cells.

Authors:  R Levis; H Huang; S Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle.

Authors:  M T Hsu; J D Parvin; S Gupta; M Krystal; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Association of the adenovirus DNA-binding protein with RNA both in vitro and in vivo.

Authors:  V G Cleghon; D F Klessig
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Isolation and characterization of the ribonucleoprotein of influenza virus.

Authors:  M W Pons; I T Schulze; G K Hirst; R Hauser
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

Review 6.  Viral RNA polymerases.

Authors:  A Ishihama; K Nagata
Journal:  CRC Crit Rev Biochem       Date:  1988

7.  Promoter analysis of influenza virus RNA polymerase.

Authors:  J D Parvin; P Palese; A Honda; A Ishihama; M Krystal
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA?

Authors:  P A Jennings; J T Finch; G Winter; J S Robertson
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

9.  Identification of the RNA polymerase-binding site on genome RNA of influenza virus.

Authors:  A Honda; K Uéda; K Nagata; A Ishihama
Journal:  J Biochem       Date:  1987-11       Impact factor: 3.387

10.  The use of DNA-cellulose for analyzing histone-DNA interactions. Discovery of nucleosome-like histone binding to single-stranded DNA.

Authors:  K B Palter; B M Alberts
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

View more
  31 in total

1.  Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication.

Authors:  H Zheng; H A Lee; P Palese; A García-Sastre
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.

Authors:  M Jaber Hossain; Sandra Perez; Zhu Guo; Li-Mei Chen; Ruben O Donis
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

4.  Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes.

Authors:  Atsushi Kawaguchi; Tadasuke Naito; Kyosuke Nagata
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Mutational analysis of the promoter required for influenza virus virion RNA synthesis.

Authors:  X Li; P Palese
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis.

Authors:  Tadasuke Naito; Yoshihiko Kiyasu; Kenji Sugiyama; Ayumi Kimura; Ryosuke Nakano; Akio Matsukage; Kyosuke Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

7.  Influenza virus PB1 protein is the minimal and essential subunit of RNA polymerase.

Authors:  M Kobayashi; T Toyoda; A Ishihama
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1.

Authors:  S K Biswas; D P Nayak
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  A plasmid-based reverse genetics system for influenza A virus.

Authors:  S Pleschka; R Jaskunas; O G Engelhardt; T Zürcher; P Palese; A García-Sastre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.